IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, recently announced that it will start offering its technology, called cryoablation, in Israel in upcoming weeks.
The company’s device is an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor and does not require hospitalization, leaves minimal to no scarring, and has a short recovery time. Destroyed tumor cells are then reabsorbed in the body over time.
The treatment, which is approved in the US and the European Union, will be available in Israel to women suffering from fibroadenomas, benign breast tumors usually found in women under 30, and for patients with malignant kidney tumors.
Article excerpts from calcalisttech.com
Since the launch of Operation Protective Edge, several helicopters have arrived at Rabin Medical Center with wounded Israel Defense Forces soldiers. Overall 39 injured soldiers have been brought to the Rabin Medical Center for emergency care. Jordan Low, a lone soldier from Baltimore, Maryland arrived at Rabin Medical Center on Sunday and is currently hospitalized in the general intensive care.
Infectious diseases are a major cause of mortality and morbidity, accounting for 25 percent of all deaths worldwide, a totaling 17 million deaths per year.